The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end the ...
The billionaire family that owns Purdue Pharma, maker of the pain medication blamed for helping fuel the nation’s opioid crisis, has agreed to increase payments to settle long-running litigation ...
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...
The Wall Street Journal on MSN16d
Purdue Pharma’s Sacklers Strike New $6.5 Billion Settlement of Opioid ClaimsPurdue Pharma’s Sackler family owners have struck a new agreement to settle mass opioid litigation against them for a total ...
The Associated Press on MSN17d
Purdue Pharma and owners to pay $7.4 billion in…Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half of what was originally anticipated before a Supreme Court decision put ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...
Officials in states and local governments claimed that the opioid crisis was exacerbated by Purdue Pharma’s OxyContin and ...
Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...
Purdue Pharma owners could pay $7.4 billion in new settlement to lawsuits over the toll of OxyContin
Members of the family who own Connecticut-based OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller ...
The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.
MISSOULA, Mont. — NBC MT Today: Impact of grant, loan pause; Purdue Pharma settlement; record year at MSO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results